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Background: Conducting randomized controlled trials on traditional Chinese non-drug therapies has been limited
by factors such as patient preference to specific treatment modality. The aim of this study is to investigate the
feasibility of applying a partially randomized patient preference (PRPP) trial model in evaluating the efficacy of two
types of traditional Chinese medicine therapies, acupuncture and cupping, for fibromyalgia while accounting for
patients’ preference of either therapeutic modality.
Methods: This protocol was approved by the Institutional Ethics Committee of affiliated Dongfang Hospital,
Beijing University of Chinese Medicine (approval number: 2013052104-2). One hundred participants with
fibromyalgia will be included in this study. Diagnosis of fibromyalgia will be based on the American College
of Rheumatology criteria. Before treatment, participants will be interviewed for their preference toward
acupuncture or cupping therapy. Fifty participants with no preference will be randomly assigned to one
of the two groups and another 50 participants with strong preference to either acupuncture or cupping will
receive what they choose. For acupuncture and cupping therapy, the main acupoints used will be tender points
(Ashi). Treatment will be three times a week for 5 consecutive weeks with a follow-up period of 12 weeks. Outcome
measures will be qualitative (patient expectation and satisfaction) and quantitative (pain intensity, quality of life,
depression assessment).
Trial registration number: NCT01869712 (in clinicaltrials.gov, on 22nd May 2013).
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Traditional Chinese medicineBackground
In the last two decades, randomized controlled trials
(RCTs) have been used to evaluate the efficacy of traditional
Chinese medicine (TCM) therapies. In most cases, these
trials have investigated herbal drugs [1]. However, limita-
tions exist when conducting RCTs for non-herbal therapies
such as acupuncture, cupping therapy, and moxibustion.* Correspondence: huijuancao327@hotmail.com
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unless otherwise stated.Therapeutic effects can be influenced by factors other than
the efficacy of the interventions themselves;such actors may
include patient preference, practitioner preference, and
patient-practitioner relationship, among others [2]. Based
on the design principle of RCTs, participants are precluded
from making their own choices during allocation to the
intervention or control arms to avoid performance bias due
to strong preference of participants who are not blinded
during the trial. Unfortunately, there is no ideal placebo
control for most types of non-drug therapies, which means. This is an Open Access article distributed under the terms of the Creative
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trials.
RCTs for non-drug therapies also have limitations as-
sociated with patient recruitment and adherence due to
their preference of treatment [3]. Patients who visit
TCM hospitals seeking non-drug treatment are likely to
prefer such therapy. This not only increases the difficulty
of recruiting for RCTs (especially for the control group)
but also may lead to a high dropout rate during the trial.
A partially randomized, patient preference (PRPP) trial
has been recommended for use in trials with potential
performance bias [4-6]. This model was first applied for
evaluating the therapeutic effect of surgery as compared
with drugs, in which blinding methods could not be
used due to the obvious inconformity between interven-
tion and control treatment. Currently, this type of trial is
widely used in studies that assess the effectiveness of a
non-drug treatment (such as surgery) [7-11]. Given the
limitations of a classical RCT, the PRPP model may be
more suitable for evaluating non-drug TCM therapies.
To date, there is no report on such trials in China to as-
sess non-drug TCM therapies. Thus, our study is aimed
at exploring the feasibility of applying the PRPP model
to appraise the therapeutic effect of two kinds of non-
drug therapies, acupuncture and cupping, while account-
ing for patient preference.
For this PRPP trial, we have chosen fibromyalgia as
the target disease for three reasons. First, as a disorder
with nonspecific symptoms of chronic widespread mus-
culoskeletal pain and stiffness [12,13], fibromyalgia ap-
pears to affect increasing numbers of people and has a
detrimental impact on their quality of life [14]. Second,
acupuncture has been widely used for treating this con-
dition [15]. Third, for pain conditions, the primary out-
come is usually defined as pain relief as measured by a
pain intensity instrument, such as a visual analog scale,
which is based on patients’ subjective reporting and may
be affected by belief, expectation, or preference of treat-
ment modality.
Many kinds of TCM non-drug modalities are used to
treat fibromyalgia. Acupuncture appears to have the
most benefit in improving the main symptoms of fibro-
myalgia compared with herbal remedies [16-20]; thus, it
is often recommended as an alternative therapy for this
disorder [21]. Cupping therapy is an ancient Chinese
healing modality. After systematically searching and ana-
lyzing clinical studies published in the last 50 years that
used cupping therapy as the main intervention, we
found that 70 of 550 studies evaluated cupping therapy
for pain conditions [22]. From these studies, it appears
that cupping therapy is effective for pain reduction in
general, but few studies looked at cupping therapy for
fibromyalgia. Our report [23] on medicinal cupping for
fibromyalgia found that, after cupping therapy, the visualanalogue scale (VAS) scores of 30 participants were re-
duced by 52.3% from baseline and the number of tender
points was 30.9% fewer than in baseline. In China, acu-
puncture and cupping therapy are commonly used in
TCM hospitals for pain management, but there have
been no trials comparing these two treatment modalities
for fibromyalgia.
Objectives
The objectives of this trial are to assess the feasibility of
applying the PRPP trial model in evaluating the thera-
peutic effect of acupuncture versus cupping, and to ob-
serve and compare the efficacies of these two therapies
for fibromyalgia.
Methods
This protocol was registered at the U.S. National Institute
of Health ClinicalTrials.gov (identifier: NCT01869712;
http://clinicaltrials.gov/ct2/show/NCT01869712?term=NC-
T01869712&rank=1). The protocol was last updated on 15
October 2013.
Study design
This will be a partially randomized patient preference
(PRPP) trial with four parallel groups: randomized cupping
therapy, non-randomized cupping therapy, randomized
acupuncture, and non-randomized acupuncture. Outcome
assessors and statisticians will be blinded (Figure 1).
In this study design, participants without preference to a
treatment modality will be randomly divided into either the
cupping or acupuncture group. Participants with strong
preferences will be assigned to their modality of choice.
The PRPP design not only enables comparisons between
participants with and without a preference and an ex-
ploration of participant characteristics associated with
preference, but also enables evaluation of total thera-
peutic effect of the two modalities, while accounting for
participant preference.
Setting and recruitment
The study will take place at the outpatient department
of acupuncture and moxibustion, Affiliated Dongfang
Hospital, Beijing University of Chinese Medicine, China.
Outpatients will be recruited. Recruitment advertising
will be via posters and flyers distributed in the hospital
and nearby communities, as well as through the Inter-
net. To increase adherence and maintain retention dur-
ing the trial, five complimentary sessions of acupuncture
or cupping therapy will be provided for all included par-
ticipants after the trial.
Estimate of sample size
The first aim of this trial will be to investigate the feasi-
bility of applying the PRPP model to evaluate the
Figure 1 Study flow chart.
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mary outcomes will be participant adherence and satis-
faction. As a feasibility study, there is no previous
study that provides relative data for us to use to calcu-
late sample size.
The second aim of this trial will be to observe the
therapeutic effect of the two types of TCM non-drug
therapies of acupuncture and cupping for fibromyalgia
with an equivalent test hypothesis. For this objective, the
outcome will be pain relief, which will be measured by
the VAS. We have used G*Power (version 3.1.2) to cal-
culate the sample size.The analysis of variance (ANOVA)
repeated measures technique was used as the statistical
method during sample size calculation and will also be
used for data analysis. To estimate the effect of cupping,
we used data from our previous study [22], in which
cupping produced a decrease in pain of 12.78 (SD =
5.88) points on the 100-mm VAS. We also used datafrom a trial on acupuncture for fibromyalgia [24] to esti-
mate changes in pain that might occur in the acupunc-
ture group. This corresponded to an estimated effect
size of .2875. Using a two-tailed test with an alpha rate
of .05, this meant that 38 participants are required per
group to achieve 80% statistical power. Thus, we will
aim for a total of 76 participants in two groups. Allowing
for a dropout of 15%, we will recruit a total of 100
participants.
Generation of the allocation sequence of randomization
Fifty patients who have no preference for either of the
two therapies (acupuncture or cupping) will be ran-
domly allocated to either the cupping or the acupunc-
ture group. We will use SAS 8.0 software to create the
sequence of randomization [25], total number of cases is
50, number of groups is 2, distribution ratio of the two
groups is 1:1.
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opaque sealed envelopes and kept by researcher A, who
will be contacted by each practitioner to provide the
allocation.
Blinding methods
As the comparisons in this trial are different, outcome
assessors and statistical analysts will be blinded. Outcome
assessors will not be involved in participant allocation or
treatment and will not be permitted to ask participants
about information on allocation or treatment.
Participants
Diagnostic criteria of fibromyalgia
Fibromyalgia will be diagnosed based on criteria formu-
lated by the American College of Rheumatology (ACR)
[26]. Key symptoms will be chronic widespread muscu-
loskeletal pain, which will be assessed using scores of a
widespread pain index (WPI) and a symptom severity
(SS) scale [26].
Inclusion criteria
1. Participants with fibromyalgia diagnosed based on
ACR criteria;
2. Participants whose scores for pain intensity are more
than 30 mm (measured by VAS);
3. Participants 20 through 60 years of age;
4. Participants who fully understand the research
process and are willing to provide informed consent.
Exclusion criteria
1. Persons with general musculoskeletal pain due to
non-fibromyalgia illness;
2. Persons with mental disorders or other serious
organic diseases, such as organ failure;
3. Persons taking oral pain medication or undergoing
other interventions for pain relief during the trial;
4. Pregnant or lactating women;
5. Persons currently participating in another clinical trial.
Approach for cases of dropout/lost to follow-up/need to screen
1. Dropout cases will be defined as enrolled
participants who miss a treatment session or refuse
treatment as scheduled. We will consider at least
80% of the planned recruitment (40 cases in each
group) to provide sufficient data for analysis.
2. Lost to follow-up will be defined as participants who
complete all treatments, but cannot be contacted for
follow-up.
3. Need to screen will be defined as enrolled participants
who have serious adverse events during the trial.Researchers will be expected to halt treatment
immediately and note the reason for the adverse event.
Interventions
Cupping group (randomized and non-randomized)
Cups: Glass cups of three sizes will be used: large, 7 cm
(edge diameter) × 9 cm (bore diameter) × 7.5 cm (height);
medium, 6 cm× 8 cm× 6 cm; small, 6 cm × 7 cm×
5.3 cm. Jar size will be chosen based on treatment site.
Acupoints: Ashi (tender) points will be selected as the
primary acupoints for flash cupping and retained cup-
ping. Bladder channel (BL) and/or Du channel (DU) will
be selected for moving cupping.
Cupping method: Retained cupping will be applied as
the primary cupping method, supplemented with flash
cupping and/or moving cupping. The procedure will be
as follows. Suction (vacuum) will be created in the cups
using flaming heat. Cups will then be applied immedi-
ately to acupoints on the BL and/or DU channels. Cups
will be moved back and forth along the channel(s) sev-
eral times. After cups are removed, flaming heat will be
used to again create vacuum in the cups, which will
then be applied to target treatment sites and retained
for 10 minutes during each session. Treatment will be
once daily, every other day, three sessions per week for
five weeks.
Acupuncture group (randomized and non-randomized)
Needles: Stainless steel disposable needles (Wujiang Cloud
Dragon Medical Instrument Company, Ltd., Jiangsu,
China) of three lengths will be used, depending on the
depth of the acupoint site: 0.25 mm× 25 mm, 0.25 mm×
40 mm, and 0.30 mm× 75 mm.
Acupoints: Ashiacupoints will be selected.
Acupuncture procedure: The skin at the acupoints will
be disinfected. Needles will be inserted and manipulated
for 15 seconds. Needle manipulation will be accom-
plished by using a twirling and up and down movement.
Needles will be retained for 30 minutes each session.
Treatment will be once daily, every other day, three ses-
sions per week for five weeks.
Other allowable interventions
Patients will be permitted to take analgesics for pain
relief during the follow-up period. Researchers will be




1. Patient adherence: Participant dropout,participants
lost to follow-up, and reasons will be recorded
(Table 1).
Table 1 Schedule for treatment and outcome measurement
Item Screening Treatment Follow-up
Session 1 (baseline) 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (+1 m) 18 (+2 m) 19 (+3 m)
Eligibility screening √
Informed consent √
Patient preference screening √
Allocation √
Patient expectation toward treatment √
Treatment √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
Widespread pain index √ √ √ √ √ √ √
Symptom severity √ √ √ √ √ √ √
Visual analogue score √ √ √ √ √ √ √
Fibromyalgia intensive questionnaire √ √ √ √ √
Hamilton depression scale √ √ √ √ √
SF-36 Health survey √ √ √ √ √
Patient satisfaction of treatment √




Recording of adverse events √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
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satisfaction will be assessed at week 5 (Table 1).
Satisfaction will be measured using a seven-score
scale, with 1 for “very satisfied” and 7 for “very
dissatisfied”.
3. Practitioner attitude for the research model:
Individual or focus group interviews will be
conducted after the trial (Table 1). All practitioners
in the study (acupuncturists and cupping therapy
practitioners) will be interviewed for their
disposition toward conducting the PRPP trial model
and their thoughts on this model compared with
traditional randomized controlled trials.
Secondary outcomes
1. Adverse events: Adverse events will be observed
during the five weeks of treatment and three months
follow-up (Table 1). Researchers will be expected to
note minor and serious adverse events that occur,
including case ID number and symptoms.
2. Patient expectation for the treatment: Patient
expectation will be assessed at week 0 (Table 1),
measured by a four-score scale, with 1 for “symptoms
totally disappeared” and 4 for “no change in symptoms”.
3. Visual analogue scale (VAS) [27] for pain intensity:
The length of the VAS we will use is 100 mm, with
“0” representing no pain and “100” representing
unbearable pain that affects appetite and quality of
sleep. Researchers will be expected to show the scaleto patients and note the pain scores. VAS for pain
will be measured once daily during week 0, at the
end of every fifth treatment session (for a total of 15
assessments during the five-week treatment period),
then during weeks 9, 13, and 17 of the follow-up
period (Table 1).
Other outcomes
1. Widespread pain index (WPI) for pain intensity: The
WPI is defined based on the ACR diagnostic criteria
for fibromyalgia [26]. The WPI will be measured once
daily during week 0, at the end of every fifth
treatment session (for a total of 15 assessments during
the five-week treatment period), then during weeks 9,
13, and 17 of the follow-up period (Table 1).
2. Symptom severity (SS) for pain intensity: SS is
defined based on the ACR diagnostic criteria [26] for
fibromyalgia. SS will be measured once daily during
week 0, at the end of every fifth treatment session
(for a total of 15 assessments during the five-week
treatment period), then during weeks 9, 13, and 17
of the follow-up period (Table 1).
3. Hamilton Depression Scale (HAMD; Chinese
translation) for depression [28]: The HAMD will
be implemented three times at weeks 0, 5, and 17
(Table 1).
4. Quality of life measured by the SF-36 Health Survey
(Chinese translation) [29]: The SF-36 will be imple-
mented three times, at weeks 0, 5, and 17 (Table 1).
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Chinese translation) for pain intensity [30]: The
FIQR will be implemented three times, at weeks 0,
5, and 17 (Table 1).
Data handling and statistical analysis
Data collection
A case report form (CRF) for each enrolled participant,
listing demographic characteristics and baseline symp-
tom spectrum, data outcome at each visit (Table 1), ad-
verse events, and analgesic use, will be completed by
outcome assessors at each visit.
Data management
EpiData Software (version 3.0.2, The EpiData Associ-
ation, Odense, Denmark) will be employed for data man-
agement. Data from CRFs will be entered and stored by
two data entry staff members. Data entry accuracy will
be ensured using the double entry method.
Statistical analysis
To evaluate the feasibility of the PRPP model, we will
use the chi-square, Cochran-Mantel-Haenszel (CMH)-
chi-square, or Fisher’s exact test (as appropriate) to com-
pare patient adherence and satisfaction toward treatment
between groups and qualitative research methods to
analyze patient and practitioner attitudes.
To assess the therapeutic effect of acupuncture and
cupping therapy for fibromyalgia, we will use the chi-
square, CMH-chi-square, or Fisher’s exact test (as appro-
priate) to compare baseline characteristics for categorical
data. Analysis of variance (normal distribution) or non-
parametric tests (skewed distribution) will compare
baseline characteristics for continuous data. Analysis of
primary outcomes will involve contrast analysis in which
cupping therapy will be compared with acupuncture.
This will indicate whether or not cupping and acupunc-
ture differ in efficacy. This analysis will be conducted
using repeat measurements in which outcomes will be
compared at each follow-up, controlling for baseline
scores. Intention-to-treat analysis[31] will be used in
which missing data will be supplemented using the value
that was assessed at the prior session (for example, if
participant drops out at treatment session 6, then all
outcome data would be noted as values at session 5). All
calculations will be performed using SPSS for Windows
(version 17.0, Chicago, Illinois), and P-values under .05
will be considered significant.
Ethical issue
This protocol, including the informed consent document
and case report form, has been approved by the Institu-
tional Ethics Committee of Beijing University of Chinese
Medicine Affiliated Dongfang Hospital (approval number:2013052104-2). All participants will be required to sign
the informed consent form. Participant names will appear
as pinyin abbreviations on CRFs. Only the practitioner
who will oversee enrollment and outcome assessors will
be aware of participants’ personal information, which will
not be shared with other researchers and practitioners.
Discussions
The average age of onset of fibromyalgia is 45 years with
morbidity increasing with age [32]. Our systematic re-
view of randomized controlled trials on TCM treatment
for fibromyalgia found that the average age of patients
was 40 to 50 yrs [20]. Thus, for this trial we will include
persons aged 20 to 60 years, in order to focus on this
high-risk group.
Researchers of this study include professionals in epi-
demiology, evidence-based medicine, biostatistics, and
clinicians, all of whom will ensure the quality of design,
application, and evaluation of this clinical trial. All acu-
puncturists and cupping therapists will be screened for
licensure in traditional Chinese medicine and clinical ex-
perience of at least one year.
Trial status
This study has been in the active recruitment phase
since July 2013.
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